Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci

Vancomycin-resistant enterococci (VRE) account for a large proportion of hospital-acquired infections. Determining optimal treatment of VRE urinary tract infections (UTIs) is challenging. The purpose of this study was to determine if a difference in efficacy or safety exists between linezolid and no...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mary Joyce Wingler, Neel R. Patel, S. Travis King, Jamie L. Wagner, Katie E. Barber, Kayla R. Stover
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2021-10-01
Sarja:	Pharmacy
Aiheet:	infectious diseases anti-infectives genitourinary enterococcus vancomycin-resistant linezolid
Linkit:	https://www.mdpi.com/2226-4787/9/4/175
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!